RECTOSIGMOID CANCER METASTATIC

This adverse event was reported 37 times

These drugs are most commonly taken by patients reporting RECTOSIGMOID CANCER METASTATIC:

# Drug Count
0 OXALIPLATIN 9
1 PANITUMUMAB 9
2 BEVACIZUMAB 8
3 FLUOROURACIL 7
4 FLUOROURACIL CREAM, 0.5% 7
5 DEXAMETHASONE 5
6 DEXAMETHASONE 1.5 MG 5
7 FRUQUINTINIB 5
8 CAPECITABINE 4
9 FILGRASTIM 4
See all common drugs associated with RECTOSIGMOID CANCER METASTATIC

RECTOSIGMOID CANCER METASTATIC is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 FRUQUINTINIB 5 0.0013
1 ZIV-AFLIBERCEPT 1 0.0008
2 PANITUMUMAB 9 0.0006
3 MIRVETUXIMAB SORAVTANSINE 1 0.0006
4 GLYCERIN SUPPOSITORY 1 0.0004
5 GLYCERIN SUPPOSITORIES 1 0.0004
6 DALTEPARIN SODIUM 3 0.0003
7 BEVACIZUMAB-AWWB 1 0.0002
8 REGORAFENIB 2 0.0002
9 LAMIVUDINE 4 0.0002
See all drugs enriched for association with RECTOSIGMOID CANCER METASTATIC